Hesham Metwalli Mousli

Dr. Hesham Metwalli Mousli

Medical research institute, Alexandria, Al Iskandarīyah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SAShaimaa Abdelaziz Abdelmoneim
Shaimaa Abdelaziz Abdelmoneim
Malik SallamMalik Sallam
Malik Sallam
DHDina Hafez
Dina Hafez
EEEhab Elrewany
Ehab Elrewany
HMHesham Metwalli Mousli
Hesham Metwalli Mousli
Ramy Mohamed GhazyRamy Mohamed Ghazy
Ramy Mohamed Ghazy
The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary vaccination series for individuals ≥18 years and most-at-risk populations. This study aimed to estimate the pooled proportion of COVID-19 vaccine booster dose uptake and intention to get the booster dose among general populations and healthcare workers (HCWs). We searched PsycINFO, Scopus, EBSCO, MEDLINE Central/PubMed, ProQuest, SciELO, SAGE, Web of Science, Google Scholar, and ScienceDirect according to PRISMA guidelines. From a total of 1079 screened records, 50 studies were extracted. Meta-analysis was conducted using 48 high-quality studies according to the Newcastle-Ottawa Scale quality assessment tool. Using the 48 included studies, the pooled proportion of COVID-19 vaccine booster dose acceptance among 198,831 subjects was 81% (95% confidence interval (CI): 75–85%, I2 = 100%). The actual uptake of the booster dose in eight studies involving 12,995 subjects was 31% (95% CI: 19–46%, I2 = 100%), while the intention to have the booster dose of the vaccine was 79% (95% CI: 72–85%, I2 = 100%). The acceptance of the booster dose of COVID-19 vaccines among HCWs was 66% (95% CI: 58–74%), I2 = 99%). Meta-regression revealed that previous COVID-19 infection was associated with a lower intention to have the booster dose. Conversely, previous COVID-19 infection was associated with a significantly higher level of booster dose actual uptake. The pooled booster dose acceptance in the WHO region of the Americas, which did not include any actual vaccination, was 77% (95% CI: 66–85%, I2 = 100%). The pooled acceptance of the booster dose in the Western Pacific was 89% (95% CI: 84–92%, I2 = 100), followed by the European region: 86% (95% CI: 81–90%, I2 = 99%), the Eastern Mediterranean region: 59% (95% CI: 46–71%, I2 = 99%), and the Southeast Asian region: 52% (95% CI: 43–61%, I2 = 95). Having chronic disease and trust in the vaccine effectiveness were the significant predictors of booster dose COVID-19 vaccine acceptance. The global acceptance rate of COVID-19 booster vaccine is high, but the rates vary by region. To achieve herd immunity for the disease, a high level of vaccination acceptance is required. Intensive vaccination campaigns and programs are still needed around the world to raise public awareness regarding the importance of accepting COVID-19 vaccines needed for proper control of the pandemic.

11 April 2023 in The TQM Journal
Verified
Journal Article
Closed access
HMHesham Metwalli Mousli
Hesham Metwalli Mousli
ISIman El Sayed
Iman El Sayed
AZAdel Zaki
Adel Zaki
SASherif Abdelmonem
Sherif Abdelmonem
Purpose: This study intends to improve the quality of venous thromboembolism (VTE) prophylaxis practices including proper VTE risk assessment and the appropriate prophylaxis measures for surgical urology patients.Design/methodology/approach: The authors applied the Six-Sigma define, measure, analyze, improve and control (DMAIC) improvement methodology in a pre–post interventional study that involved all adult patients above 18 years old indicated and scheduled for urology surgical interventions including endoscopic urological surgeries in a urology specialized 60-bed hospital. The pre-intervention sample included all patients meeting the inclusion criteria over a period of six months. Post-intervention sample included all patients meeting the inclusion criteria over a period of six months. The improvement areas included both the VTE risk assessment as well as the VTE prophylaxis prescription.Findings: DMAIC methodology has achieved a substantial sustained improvement in surgical urology VTE prophylaxis practices with an average of 70% on both levels; VTE risk assessment practices and VTE prophylaxis prescribing practices were statistically significant. The post-intervention results also showed a statistically controlled process with no special cause variations. Based on the study results, the Six-Sigma DMAIC methodology can be considered of high value when applied in healthcare clinical practice improvement projects.Research limitations/implications: The project study includes some pitfalls that can be addressed as follows: 1. The lack of VTE rate incidence tracking. This limitation can be partly refuted when the authors conduct a literature review and explore that the VTE prophylaxis effectiveness had been proven with sufficient evidence to an extent that pushed several scientific societies to develop their own guidelines to support VTE prophylaxis. (Algattas et al., 2018). 2. Another limitation of this study can be that it handled only surgical patients and more specifically surgical urology patients. Of course, VTE prophylaxis is a crucial life-threatening problem not only for the surgical admitted patients but also for all the medical admitted patients either in hospital wards or ICUs. However, the prediction that surgical patients especially surgical urology patients are more prone to VTE development risk as they have -in several cases-two or three main additive risk factors which are age, procedure duration and malignancy in elderly men. (Tikkinen et al., 2014). So, the authors consider the study project to be a prototype that hopefully can be utilized for future study projects that will manage both other surgical specialty patients and medical patients on the national level and can track accurately and effectively report the VTE incidence rates.Practical implications: Several recommendations can be extracted from the research project that is summarized in the following points: Paying focused attention to continuous healthcare quality improvement initiatives and projects as a main approach for healthcare improvement especially for the public health-related problems. This might be achieved through periodic region-specific or specialty-specific focus groups from which public health problems could be addressed and prioritized to be considered as a part of country healthcare campaigns regarding cost-utility and feasibility studies. The adoption of a system thinking approach in dealing with the improvement strategies; all efforts and resources are to be employed to achieve a common objective. This includes the generation of a national-wide electronic health information system that can aid in healthcare resource allocation and direct the healthcare efforts towards the most important, high-priority public health problems. Electronic national-wide health record is really an effort, and resources consuming activity, but actually, it's worth exerting efforts, and its valuable outcomes may be seen several years later. 3. Development of unified national specialized VTE prophylaxis pathways to standardize the patient-specific VTE prophylaxis plans. Standardization of healthcare pathways enables healthcare professionals to follow an evidence-based practice which will be reflected on the improvement of healthcare quality level, cost-effectiveness enhancement, and timely patient care on all levels especially in high critical areas like ER and ICU. 4. Incorporation of VTE prophylaxis costs in the universal health insurance diagnosis-related group (DRG) insurance packages and service pricing. Universal health insurance is a nationwide strategy that is aiming to cover all Egypt residents by the year 2030. Universal health insurance is being following the DRG reimbursement policy that is thought to control all the healthcare-associated costs so, the VTE prophylaxis costs shall be added as the main cost item to encourage all healthcare facilities to follow an evidence-based VTE prophylaxis pathway taking into consideration the high-risk patient categories who will definitely represent a high-cost burden on the long run if they suffer a VTE event.Originality/value: DMAIC improvement methodology applications in healthcare are still relatively limited, especially on the clinical level. The study can be considered one of a kind in Egypt dealing with a comprehensive DMAIC methodology application on the clinical level.

18 December 2025 in International Journal of Health Care Quality Assurance
Verified
Journal Article
Closed access
HMHesham Metwalli Mousli
Hesham Metwalli Mousli
HEHagar Elmasry
Hagar Elmasry
EMElsayed Mousa
Elsayed Mousa
MOMahitab Ouda
Mahitab Ouda
NENayera Elsayed
Nayera Elsayed
MMMohamed Metwally Mosly
Mohamed Metwally Mosly
Purpose: This study aims to assess the current state of awareness and preparedness for Mass Casualty Incidents (MCIs) among hospital pharmacies in Egypt, focusing on the availability of disaster plans either for pharmacy or for a hospital as a whole, participation in drills and the perceived adequacy of essential medication stocks. Design/methodology/approach: A descriptive, cross-sectional study was conducted using a validated, self-administered questionnaire distributed to licensed pharmacists across various public, private, and university teaching hospitals, across different governorates in Egypt. Findings: Our findings show significant gaps in preparedness and awareness of many aspects of the mass causality events' handling. While just over half of participants reported that they have a pharmacy-specific disaster plan, over a third (36.6%) were unaware of their hospital's overall disaster plan. A striking 75% of pharmacists had never participated in a disaster drill. Confidence in medication stocks was high for common drugs like analgesics (70.3% agreed adequate). 65.4% of pharmacists reporting that chemical weapon antidote stocks were insufficient. Larger, better-resourced hospitals were significantly more likely to have a formal disaster plan. Originality/value: This research is the first focused examination of hospital pharmacy preparedness for MCIs in Egypt, which fills a significant gap in the national and regional literature. The findings provide novel, practical evidence that goes beyond intuitive opinion to identify specific readiness gaps, offering a critical foundation for stakeholders to build on.

16 July 2026 in International Journal of Health Care Quality Assurance
Verified
Journal Article
Closed access
MMMohamed Metwally Mosly
Mohamed Metwally Mosly
HMHesham Metwalli
Hesham Metwalli
HMHesham Metwalli Mousli
Hesham Metwalli Mousli
Purpose: To apply a two-phase statistical process control (SPC) framework to monitor ICU Day-2 glycemic performance, detect SPC-defined glycemic instability, and identify clinical predictors of out-of-control Day-2 glycemic patterns in a tertiary hospital ICU in Egypt's Delta region. Design/methodology/approach: A prospective observational cohort study was conducted in an adult mixed medical-surgical ICU. Phase I data included 300 patients, each with four glucose measurements on ICU Day-2, and were used to estimate empirical x̄-chart control limits. Phase II surveillance applied the fixed Phase I limits to 1,000 additional patients, each with four ICU Day-2 glucose measurements. Nelson Rules 1 and 2 were used as pre-specified operational signal-detection criteria to identify extreme excursions and sustained unit-level process shifts. Multivariable logistic regression was used to explore clinical factors associated with SPC-defined out-of-control Day-2 glycemic status. Findings: In Phase II, 505/1,000 (50.5%) patient subgroups signaled “out-of-control” by the union of Nelson rules. Rule-1 limit exceedances occurred in 150 subgroups, while Rule-2 shift signaling affected 413 subgroups (35 distinct run events). In adjusted analyses, higher illness severity (APACHE II), sepsis, older age, higher baseline HbA1c, vasopressor use, corticosteroid use, and comorbidity burden (CKD and/or liver disease) increased the odds of “out-of-control” status; higher caloric intake was associated with lower odds. BMI, sex, and surgical admission type were not significant predictors. Research limitations/implications: Observational design precludes causal inference and assessment of real-time SPC impact. Excluding DKA/HHS and stays <48 h may limit generalizability. Subgrouping (n = 4) favors shift detection but may mask very short-term variability. Single-center results may not generalize to ICUs with different nutrition/sedation and glycemic management practices. Practical implications: A combined SPC-and-regression framework can provide early operational surveillance of ICU Day-2 glycemic instability and may support targeted, data-driven quality-improvement interventions. However, prospective interventional studies are required to determine whether SPC-guided glycemic management improves clinical outcomes. Originality/value: This study combines Phase-I-derived SPC limits with Phase II surveillance and multivariable risk modeling to measure and explain Day-2 glycemic special-cause variation in a resource-relevant tertiary ICU environment.